OSAIC HOLDINGS, INC.

Position in PYXS — Pyxis Oncology, Inc.

CIK 1677044 SCOTTSDALE, AZ

Position in PYXS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$20,032

+$225 QoQ

Shares Held

13,721

-20.3% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 78 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

OSAIC HOLDINGS, INC. holds $166,775,917 across 399 Biotechnology names. PYXS ranks #179 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,972	$19,635,254
2	BBIO	BridgeBio Pharma, Inc.	217,084	$16,120,657
3	ALNY	Alnylam Pharmaceuticals, Inc.	46,653	$15,436,076
4	HALO	Halozyme Therapeutics, Inc.	183,486	$11,858,698
5	LGND	Ligand Pharmaceuticals Inc	58,150	$11,609,647
6	REGN	Regeneron Pharmaceuticals, Inc.	12,238	$9,455,565
7	TGTX	Tg Therapeutics, Inc.	271,608	$9,022,817
8	ABUS	Arbutus Biopharma Corp	1,348,127	$6,066,571

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$20,032	13,721	-20.3%	Shares	Defined	2026-05-15
2025-12-31	$19,807	17,224	+13.2%	Shares	Defined	2026-02-17
2025-09-30	$33,790	15,221	-14.1%	Shares	Defined	2025-11-14
2025-06-30	$19,493	17,721	-20.8%	Shares	Defined	2025-09-04
2025-03-31	$21,931	22,379	0.0%	Shares	Defined	2025-05-12
2024-12-31	$34,911	22,379	+284.5%	Shares	Defined	2025-06-06
2024-09-30	$21,363	5,821	+33.2%	Shares	Sole	2024-11-13
2024-06-30	$14,468	4,371	+40.1%	Shares	Defined	2024-08-13
2024-03-31	$13,295	3,121	+18.4%	Shares	Sole	2024-05-10
2023-12-31	$4,744	2,636	-66.1%	Shares	Sole	2024-02-12
2023-09-30	$15,494	7,786	0.0%	Shares	Sole	2023-11-13
2023-06-30	$19,932	7,786	-2.7%	Shares	Defined	2023-08-21
2023-03-31	$32,080	8,000	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.